California Institute of Regenerative Medicine not reforming itself enough, or fast enough, panel says

By Dave Andrusko When last we visited the California Institute of Regenerative Medicine,  the CIRM was under tremendous pressure to become more “accountable” and more “transparent,” especially when it came to what pro-life bioethicist Wesley Smith has called “institutional back scratching.” In case you’ve missed our many stories about CIRM, it was established after voters …

Continue reading "California Institute of Regenerative Medicine not reforming itself enough, or fast enough, panel says"

Prestigious Panel criticizes California Institute of Regenerative Medicine

By Dave Andrusko For years, bioethicist Wesley J. Smith has kept close tabs on the California Institute of Regenerative Medicine, established after voters in 2004 approved a state ballot initiative, Proposition 71, which funded embryonic stem cell/human cloning research using $3 billion in bonds. Over the past year, in particular, there have been mounting calls …

Continue reading "Prestigious Panel criticizes California Institute of Regenerative Medicine"

The California Institute for Regenerative Mendacity

By Wesley J. Smith Here’s how the pro embryonic stem cell/human cloning advocacy game is played. First, the public faces of patients and their loved ones promise CURES! CURES! CURES! Then, when you call the campaign on the mendacity, they claim, “The scientists have never said that in the literature.” Of course they didn’t. They …

Continue reading "The California Institute for Regenerative Mendacity"

California Stem Cell Agency Helps Executives, Not Patients

By David Prentice Jack Dolan of the Los Angeles Times takes California’s stem cell agency (California Institute of Regenerative Medicine– CIRM) to task for the exorbitant salaries paid to its executives, while other California agencies cut back and the state wrestles with covering an enormous budget deficit. Investment banker Jonathan Thomas was elected the new …

Continue reading "California Stem Cell Agency Helps Executives, Not Patients"